Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells

PLoS Biology

Volumn 2, Issue 12, 2004, Pages

  Hematti, Peiman ^a,h   Hong, Bum Kee ^a   Ferguson, Cole ^a   Adler, Rima ^a   Hanawa, Hideki ^b   Sellers, Stephanie ^a   Holt, Ingeborg E ^c   Eckfeldt, Craig E ^d   Sharma, Yugal ^e   Schmidt, Manfred ^f   Von Kalle, Christof ^g   Persons, Derek A ^b   Billings, Eric M ^e   Verfaillie, Catherine M ^d   Nienhuis, Arthur W ^b   Wolfsberg, Tyra G ^c   Dunbar, Cynthia E ^a   Calmels, Boris ^a,i  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF FREIBURG   (Germany)

^g CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^h UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

ⁱ INSTITUT PAOLI CALMETTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; VIRUS VECTOR;

ARTICLE; BIOINFORMATICS; COMPUTER MODEL; GENE SEQUENCE; GENOMICS; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; MOLECULAR CLONING; MURINE LEUKEMIA VIRUS; NONHUMAN; RHESUS MONKEY; SIGNAL TRANSDUCTION; SIMIAN IMMUNODEFICIENCY VIRUS; STEM CELL; TRANSPLANTATION;

MACACA MULATTA; MURINAE; MURINE LEUKEMIA VIRUS; PRIMATES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 20044396722     PISSN: 15449173     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pbio.0020423     Document Type: Article

References (53)

1. Aiuti A, Slavin S, Aker M, Ficara F, Deola S, et al. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
2. + cells. J Virol 74: 1286-1295.
3. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
4. Bartholomew C, Morishita K, Askew D, Buchberg A, Jenkins NA, et al. (1989) Retroviral insertions in the CB-1/Fim-3 common site of integration activate expression of the Evi-1 gene. Oncogene 4: 529-534.
5. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, et al. (2003) Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 101: 2099-2114.
6. Bernardi G, Olofsson B, Filipski J, Zerial M, Salinas J, et al. (1985) The mosaic genome of warm-blooded vertebrates. Science 228: 953-958.
7. Best RG, Diamond D, Crawford E, Grass FS, Janish C, et al. (1998) Baboon/human homologies examined by spectral karyotyping (SKY): A visual comparison. Cytogenet Cell Genet 82: 83-87.
8. Bordereaux D, Fichelson S, Sola B, Tambourin PE, Gisselbrecht S (1987) Frequent involvement of the fim-3 region in Friend murine leukemia virus-induced mouse myeloblastic leukemias. J Virol 61: 4043-4045.
9. Bushman FD (1999) Host proteins in retroviral cDNA integration. Adv Virus Res 52: 301-317.
10. Caron H, van Schaik B, van der Mee M, Baas F, Riggins G, et al. (2001) The human transcriptome map: Clustering of highly expressed genes in chromosomal domains. Science 291: 1289-1292.
11. Chubb JR, Bickmore WA (2003) Considering nuclear compartmentalization in the light of nuclear dynamics. Cell 112: 403-406.
12. Coffin JM, Hughes SH, Varmus HE (1997) Retroviruses. Plainview, New York: Cold Spring Harbor Laboratory Press. 843 p.
13. Cornetta K, Morgan RA, Anderson WF (1991) Safety issues related to retroviral-mediated gene transfer to humans. Hum Gene Ther 2: 5-14.
14. Crawford GE, Holt IE, Mullikin JC, Tai D, Blakesley R, et al. (2004) Identifying gene regulatory elements by genome-wide recovery of DNase hypersensitive sites. Proc Natl Acad Sci USA 101: 992-997.
15. Donahue RE, Dunbar CE (2001) An update on the use of non-human primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells. Hum Gene Ther 12: 607-617.
16. Dudley JP (2003) Tag, you're hit: Retroviral insertions identify genes involved in cancer. Trends Mol Med 9: 43-45.
17. Elleder D, Pavlícek A, Paces J, Hejnar J (2002) Preferential integration of human immunodeficiency virus type 1 into genes, cytogenetic R bands and GC-rich DNA regions: insight from the human genome sequence. FEBS Lett 517: 285-286.
18. Gilbert N, Boyle S, Fiegler H, Woodfine K, Carter NP, et al. (2004) Chromatin architecture of the human genome: Gene-rich domains are enriched in open chromatin fibers. Cell 118: 555-566.
19. Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, et al. (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346: 1185-1193.
20. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256.
21. Hanawa H, Hematti P, Keyvanfar K, Metzger ME, Krouse A, et al. (2004) Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood 103: 4062-4069.
22. + cells is superior to G-CSF or G-CSF+Flt3-L-mobilized cells in nonhuman primates. Blood 101: 2199-2205.
23. Hindmarsh P, Leis J (1999) Retroviral DNA integration. Microbiol Mol Biol Rev 63: 836-843.
24. Horn PA, Morris JC, Bukovsky AA, Andrews RG, Naldini L, et al. (2002) Lentivirus-mediated gene transfer into hematopoietic repopulating cells in baboons. Gene Ther 9: 1464-1471.
25. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70.
26. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, et al. (2003) The UCSC Genome Browser database. Nucl Acids Res 31: 51-54.
27. Kent WJ (2002) BLAT - The BLAST-like alignment tool. Genome Res 12: 656-664.
28. Kiem HP, Sellers S, Thomasson B, Morris JC, Tisdale JF, et al. (2004) Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: No progression to clonal hematopoiesis or leukemia. Mol Ther 9: 389-395.
29. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860-921.
30. Laufs S, Gentner B, Nagy KZ, Jauch A, Benner A, et al. (2003) Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells. Blood 101: 2191-2198.
31. Li Z, Dullmann J, Schiedlmeier B, Schmidt M, von Kalle C, et al. (2002) Murine leukemia induced by retroviral gene marking. Science 296: 497.
32. Mahy NL, Perry PE, Bickmore WA (2002) Gene density and transcription influence the localization of chromatin outside of chromosome territories detectable by FISH. J Cell Biol 159: 753-763.
33. Miller AD, Buttimore C (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6: ((8)) 2895-2902.
34. Mitchell RS, Beitzel BF, Schroder ARW, Shinn P, Chen H, et al. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: e234.
35. Moolten FL, Cupples LA (1992) A model for predicting the risk of cancer consequent to retroviral gene therapy. Hum Gene Ther 3: 479-486.
36. Morishita K, Parker DS, Mucenski ML, Jenkins NA, Copeland NG, et al. (1988) Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell 54: 831-840.
37. Muller S, Wienberg J (2001) "Bar-coding" primate chromosomes: Molecular cytogenetic screening for the ancestral hominoid karyotype. Hum Genet 109: 85-94.
38. National Research Council (1985) Guide for the care and use of laboratory animals. National Institutes of Health publication no. 85-23 Bethesda (Maryland): Public Health Service.
39. Negre D, Cosset FL (2002) Vectors derived from simian immunodeficiency virus (SIV). Biochimie 84: 1161-1171.
40. Page SL, Goodman M (2001) Catarrhine phylogeny: Noncoding DNA evidence for a diphyletic origin of the mangabeys and for a human-chimpanzee clade. Mol Phylogenet Evol 18: 14-25.
41. Schmidt M, Zickler P, Hoffmann G, Haas S, Wissler M, et al. (2002) Polyclonal long-term repopulating stem cell clones in a primate model. Blood 100: 2737-2743.
42. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, et al. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
43. Stewart CB, Disotell TR (1998) Primate evolution - In and out of Africa. Curr Biol 8: R582-R588.
44. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
45. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, et al. (2002) New genes involved in cancer identified by retroviral tagging. Nat Genet 32: 166-174.
46. Takatoku M, Sellers S, Agricola BA, Metzger ME, Kato I, et al. (2001) Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest 108: 447-455.
47. Tisdale JF, Hanazono Y, Sellers SE, Agricola BA, Metzger ME, et al. (1998) Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92: 1131-1141.
48. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, et al. (2001) The sequence of the human genome. Science 291: 1304-1351.
49. Versteeg R, van Schaik BD, van Batenburg MF, Roos M, Monajemi R, et al. (2003) The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes. Genome Res 13: 1998-2004.
50. Volpi EV, Chevret E, Jones T, Vatcheva R, Williamson J, et al. (2000) Large-scale chromatin organization of the major histocompatibility complex and other regions of human chromosome 6 and its response to interferon in interphase nuclei. J Cell Sci 113: 1565-1576.
51. Wu T, Bloom ML, Yu JM, Tisdale JF, Dunbar CE (1998) Murine bone marrow expressing the neomycin resistance gene has no competitive disadvantage assessed in vivo. Hum Gene Ther 9: 1157-1164.
52. + progenitors using clinically feasible methods. Mol Ther 1: 285-293.
53. Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.